Background: Mapping the hypoxic brain in acute ischemic stroke has considerable potential for both diagnosis and treatment monitoring. PET using 18 F-fluoro-misonidazole (FMISO) is the reference method; however, it lacks clinical accessibility and involves radiation exposure. MR-based T2 0 mapping may identify tissue hypoxia and holds clinical potential. However, its validation against FMISO imaging is lacking. Here we implemented back-to-back FMISO-PET and T2 0 MR in rodents subjected to acute middle cerebral artery occlusion. For direct clinical relevance, regions of interest delineating reduced T2 0 signal areas were manually drawn.
Introduction
In acute ischemic stroke, imaging the hypoxic brain at risk of impending infarction is an important goal. 1 PET-based methods to indirectly map brain hypoxia using oxygen-15 labeled compounds are complex, expensive and scarcely available. 2 The direct PET hypoxia tracer 18 F-fluoro-misonidazole (FMISO) accumulates over time in hypoxic but non-necrotic brain areas thanks to irreversible covalent trapping of its reduced form to cell organelles 3 and has been extensively used in acute ischemic stroke studies, both pre-clinical [4] [5] [6] [7] [8] and clinical. [9] [10] [11] [12] [13] [14] [15] [16] However, FMISO PET remains poorly accessible in the acute clinical setting, and in addition involves radiation exposure. More widely accessible, non-invasive approaches to map acute brain hypoxia are therefore highly desirable. Recent efforts have aimed to develop various MR-based approaches to directly map tissue hypoxia, 17, 18 all based on the T2* susceptibility effect reflecting the local deoxyhemoglobin/ oxyhemoglobin ratio. Among these, T2 0 mapping is particularly promising as it provides direct information on local deoxyhemoglobin concentration, and hence should be sensitive to tissue hypoxia.
Although previous work in stroke patients and rodent models found T2 0 reductions in hypoperfused areas and within apparent diffusion coefficient (ADC) lesions, consistent with tissue hypoxia, [19] [20] [21] [22] [23] [24] no direct validation of T2 0 imaging against PET has been reported so far. Furthermore, all the above experimental and clinical studies reported T2 0 values within hypoperfused or ADC lesion regions of interest (ROIs), but did not directly address the clinically relevant question whether reduced T2 0 signal, assumed to represent tissue hypoxia, can be reliably delineated by visual inspection of T2 0 maps.
Aims and hypothesis
The present PET and MR back-to-back study therefore aimed to directly test the hypothesis that T2 0 lesions truly reflect acute tissue hypoxia. To this end, we assessed in a rodent stroke model whether areas of reduced T2 0 signal (i) exhibit high FMISO uptake; and (ii) topographically match to FMISO hypoxia lesions. The imaging protocol exploited the specific feature of intravenously administered FMISO to slowly accumulate in hypoxic tissue over 2.5 h. Accordingly, MR data acquisition was carried out while FMISO accumulated in hypoxic tissue, and actual PET data acquisition was carried out once MR acquisition was complete. To test the above hypothesis, we determined if FMISO uptake is effectively higher within the visually delineated T2 0 lesion ROIs, and how well the latter overlaps FMISO lesions. Because the ischemic core is expected to exhibit only mild residual hypoxia, we also predicted that the T2 0 lesion ROI would only marginally overlap with the ADC lesion ROI. In addition, as an ancillary substudy, we aimed to confirm the presence of hypoperfusion within the T2 0 lesion ROIs in our setting. Finally, to assess reliability, we determined the inter-rater reproducibility in T2 0 lesion ROI delineation.
Material and methods
This study was approved by the University of Cambridge Ethical Review Panel, who required that the study be designed so as to keep the number of animals to a minimum, yet sufficient to obtain meaningful results, in accordance with the legislation of UK Animals Scientific Procedures Act 1986. Accordingly, five animals are considered sufficient to provide a proof-of-concept study addressing a single, well-defined hypothesis. The large human resources and costs involved in the present complex studies were another constraint. Animal experiments complied with the ARRIVE guidelines. As no early death or other complications occurred, all five experimental subjects are reported.
Subjects
Adult male Wistar rats (n ¼ 5, 385 AE 22 g) were used. This strain was selected because it has slower stroke evolution than other strains, 25 which was relevant for this study where MR and PET data were to be compared over 2.5 h after middle cerebral artery occlusion (MCAO), see protocol below.
Surgical procedures
Under isoflurane anesthesia, spontaneously breathing rats underwent filament MCAO (online supplemental methods). Clear ischemic lesions were consistently present on diffusion-weighted MR (DWI), FMISO PET and tetrazolium chloride (TTC) staining (see the Results section).
Imaging protocol
The imaging protocol is detailed in the online supplemental methods. In brief, immediately following MCAO (median: 3 min, range: 1-7 min), the anesthetized animal was intravenously administered 18 F-FMISO as a slow bolus, and transferred to the 4.7T MR scanner. Median time from FMISO injection to start of MR acquisition was 12 min (range: 10-15 min).
MRI
The protocol timelines are depicted in Figure 1 , and detailed in online supplemental methods. Following a T2-weighted (T2w) scan for coregistration purposes, the following sequences were acquired twice directly back-to-back (to be referred to as ''time point 1'' and ''time point 2''): DWI, multiecho T2 and multiecho T2*. Overall scanning time for each block was 44 min 26 s. In three animals, dynamic susceptibility contrast (DSC) perfusion-weighted MRI was acquired immediately after the second MR block.
PET
Once MR acquisition complete, the animal was transferred to a microPET. FMISO emission data were acquired from 120 to 150 min post-injection, followed by transmission data. See online supplemental methods for details. The attenuation-corrected FMISO image was converted to a standardized uptake value (SUV) image, using the injected activity and animal weight.
Tetrazolium chloride
Immediately after completion of PET scanning, TTC staining was carried as detailed in the online supplemental methods. ROIs delineating the lesion across all brain sections were independently drawn by two observers using ImageJ, and any disagreement subsequently resolved by consensus.
MR image processing T2 0 maps. T2 0 maps were generated as detailed in the online supplemental methods. This process yielded maps of absolute T2 0 for each rat and each MR acquisition block. Image coregistration procedures are detailed in the online online supplemental methods.
ROI definition and data analysis. For each time point, T2 0 lesion ROIs, i.e. hypointense areas compared to contralateral corresponding regions, were independently delineated on the T2 0 maps by two observers (online supplemental methods). Consensus ROIs were used for further calculations and comparisons.
ADC lesion ROIs were automatically generated using ADC < 530 Â 10 À6 mm 2 /s. 26 Finally, FMISO lesion ROIs were automatically derived on the SUV images according to an automated statistical voxel-based method detailed elsewhere, 8 applying p ¼ 0.01 as cut-off.
Dimensionless weighted mean affected/unaffected side-to-side ratios for the above variables were calculated following the generation of mirror ROIs on the contralesional hemisphere (online supplemental methods).
Perfusion data analysis. MR-DSC data were analyzed using standard methodology (online supplemental methods) to generate quantitative CBF, CBV, MTT, and TTP maps.
Statistical analysis
Inter-observer agreement was assessed using the percent geometrical overlap between the T2 0 ROIs from both observers, calculated for each time point as the area of intersection between, divided by the average of, the two ROIs, multiplied by 100; a weighted average % overlap was then computed across slices. The closer this index is to 100%, the more similar the two ROIs are. The overlap between the T2 0 and ADC ROIs, and that between the T2 0 and FMISO lesion ROIs, was expressed relative to the T2 0 lesion ROI volume. The overlap between the TTC ROIs from the two observers was computed as with the T2 0 lesion ROIs. Finally, CBF, CBV, MTT, and TTP ratios within the time point 2 T2 0 lesion ROIs versus mirror ROIs were computed.
Given the small sample not permitting Wilcoxon non-parametric tests, parametric tests were used throughout. Correction for multiple tests was not considered given the biologically straightforward hypotheses. Two-tailed p < 0.05 was considered significant save for the perfusion data where one-tailed p was used given the sample size and confirmatory aim only (n ¼ 3). Results Figure 2 illustrates typical imaging findings from this study.
Inter-observer agreement
The mean (AESD) % overlap in T2 0 lesion ROIs between the two observers was 66 AE 29% and 43 AE 35% at time points 1 and 2, respectively. Online supplemental Figure 1 illustrates examples of original and consensus T2 0 lesion ROIs.
FMISO SUV in T2 0 consensus ROIs
The mean FMISO SUV value within the T2 0 consensus ROI was almost twice higher than in mirror ROI (Table 1) , which was statistically significant at time point 2 and not quite at time point 1 (no significant differences between time points). Also shown for the sake of completeness are the SUV values within the ADC ROI, which were higher than in the T2 0 lesion ROI but not significantly so.
Volume of the T2 0 consensus, FMISO and ADC ROIs
The volumes of the T2 0 consensus and ADC ROIs for each rat and each time point are shown in Table 2 , together with the FMISO ROI volumes.
Overlap between the T2 0 consensus ROI and the FMISO lesion ROI
Excluding the rat with no T2 0 ROI at time point 1 ( Table 2) , the % overlap between the consensus T2 0 lesion ROI and the FMISO lesion ROI ranged from 0 Figure 2 . Representative T2, T2*, T2 0 , and ADC maps of the same coronal brain section from rat #5, obtained at time-points 1 (top) and 2 (bottom), also showing for the latter the CBF, CBV and TTP images (MTT image not shown as almost identical to the TTP image). Also shown are the corresponding R2 0 images obtained by inverting the T2 0 images. To the right is shown the coregistered FMISO SUV image, acquired 120-150 min after tracer injection (see Figure 1 ) but representing the ''history'' of tracer behavior in brain since administration (see the Discussion section). The high FMISO uptake area (in yellow) reflects tracer retention in hypoxic areas. The images depict reduced T2 0 (and increased R2 0 ) signal in the affected MCA territory at both time points, geometrically matching the hypoperfused areas. There is substantial overlap of the T2 0 lesion with the FMISO high uptake region, and little overlap with the ADC lesion. These images also illustrate the lack of definite borders of the T2 0 lesions. Note the good quality of the original T2 and T2* images. Next to the CBF, CBV and TTP images are shown pseudocolor scales used to display these images, in units of ml/100 g min, ml/100 g and seconds, respectively. The monocolor scale (in SUV units; see the Methods section) used to display the FMISO image is shown below the latter. See Tables 1 and 3 for the average FMISO and perfusion values within the T2 0 lesion ROIs.
International Journal of Stroke, 12 (7) (for the two smallest T2 0 ROIs) to 96%, with a mean (AE1SD) of 44 (AE39.6%) and 55.6 (AE36.2%) at time points 1 and 2, respectively.
T2 0 consensus ROI versus ADC ROI
As predicted, the overlap between the T2 0 consensus ROI and the ADC ROI was very small at both time points, even excluding the three zero volumes, and ranged from 0 for the smallest T2 0 or ADC lesions to 23% for the largest ADC lesion, with means (AE1SD) of 1.0% (AE1.7%) and 11.0% (AE9.2%), respectively (not significantly different from each other).
Perfusion within the T2 0 lesion ROIs (time-point 2 only)
As expected, the CBF and CBV ratios within the T2 0 consensus lesion ROIs were significantly reduced, and the TTP and MTT ratios significantly elevated (Table 3 ).
TTC staining
All animals displayed a TTC lesion (Figure 3 ). Interobserver agreement between lesions was 76.6%. The volumes of the TTC lesion consensus ROIs are shown in Table 2 . 
Discussion
Consistent with our hypothesis, FMISO uptake was higher ($2-fold) in the T2 0 lesion ROI relative to its mirror ROI, and there was substantial ($50%) overlap between the T2 0 and FMISO lesion ROIs. These novel findings document that the T2 0 lesion effectively reflects acutely hypoxic tissue after stroke. Consistent with the idea that the T2 0 lesion is largely distinct from the ischemic core, it only slightly overlapped with the ADC lesion. Finally, consistent with previous literature, the T2 0 lesion ROI was clearly hypoperfused.
To allow biologically meaningful comparison of the T2 0 maps to the FMISO images, the T2 and T2* data were acquired at two time points covering the early and most meaningful part of FMISO brain uptake. PET data acquisition was then carried out 120-150 min post-FMISO administration. FMISO images acquired in this time-frame represent the ''history'' of FMISO uptake since tracer injection. 3 Thus, the T2 0 and FMISO images largely covered the same period of tissue hypoxia. Note that as previously documented, marked tracer accumulation does take place in ischemic areas in spite of prevailing hypoperfusion. 4 The FMISO lesion was defined using automated voxel-based statistical mapping deriving an upper threshold from FMISO uptake in the unaffected hemisphere, 8 using p < 0.01 as cut-off. Applying more stringent thresholds (e.g. 0.001 and 0.0001) in post hoc sensitivity analyses showed only slightly smaller overlaps, as this has only small effects on FMISO ROI volumes. 8 As hypothesized, the T2 0 lesion ROI showed markedly higher FMISO uptake than mirror ROIs, together with substantial overlap with the FMISO lesion. There is no previous T2 0 versus PET hypoxia study for direct comparison. As also predicted based on the notion that dead or dying neurons are less hypoxic, 27 the T2 0 lesion overlapped little with the ADC lesion. Thus, our data directly establish that the T2 0 lesion effectively reflects acutely hypoxic, but mainly non-core tissue (see Figure 2 ).
The incomplete overlap between the T2 0 and FMISO lesion ROIs, with the latter larger than the former ( Table 2 and Figure 2 ), may in part relate to intrinsic biological differences between these two hypoxia markers. While T2 0 reflects the local balance between oxygenated and reduced hemoglobin, 17 FMISO trapping expresses covalent binding to intracellular molecules taking place only in hypoxic conditions. 3 A recent clinical study reported high FMISO uptake in the core diffusion lesion, 9 as also true here (Table 1 and Figure 2) , and previous rodent studies found high FMISO uptake in mildly ischemic areas. 8 Thus, FMISO trapping appears to takes place not just in the ischemic penumbra but also to some extent in the early core and oligemia.
That in our study the T2 0 lesions were hypoperfused is consistent with substantial previous evidence. Thus, hypoperfused areas were found to have reduced T2 0 values in one previous rat study which presented images but no actual data 21 as well as increased R2 0 values in a monkey study 24 (note: R2 0 ¼ 1/T2 0 ). In another rat study assessing T2 0 and perfusion within the DWI lesion at 90 min following 60 min MCAO, 22 T2 0 tended to decrease in persistently hypoperfused DWI lesions. Two clinical studies in acute stroke 19, 20 also reported significantly reduced T2 0 within hypoperfused ROIs. Finally, in patients with high-grade carotid artery stenosis or occlusion, Seiler et al. 23 also found reduced T2 0 within chronically oligemic areas. Importantly, however, none of the above studies actually delineated low T2 0 lesions as done here. Of note, local increases in cerebral blood volume (CBV) are known to potentially cause artefactual reductions in T2 0 . 17, 28 However, in our study CBV was reduced, not increased, within the T2 0 lesions, consistent with previous animal imaging studies consistently showing reduced CBV within the acutely ischemic area, be it using PET, [29] [30] [31] CT perfusion, 32 MR DSC perfusion, 33 steady-state MR susceptibility imaging with ultra-small iron-oxide particles 34, 35 or functional ultrasound. 36 International Journal of Stroke, 12 (7) The overlap in T2 0 lesion ROIs independently drawn by the two observers was suboptimal, suggesting that although T2 0 lesions are conspicuous, their boundaries may be difficult to delineate (see Figure 2 ). This cannot be explained by inadequate MCAO as shown by the presence of ADC, FMISO, and TTC lesions in all subjects, but is consistent with a clinical study showing limited inter-rater reproducibility in T2 0 lesion visual identification. 37 Ill-defined borders of T2 0 lesions also appeared to affect previously published T2 0 maps both from animal studies 21, 22, 24 and acute stroke patients, 20,38 even after head motion correction. 19 This feature might be related to the intrinsic nature of the T2 0 signal, together with local changes in CBV and the voxel-based divisions and subtractions involved in generating T2 0 maps (see online supplemental methods).
The main advantage of T2 0 over T2* is its independence from T2 effects, and hence from vasogenic edema, 17 which can develop rapidly after experimental stroke, 39 with T2-weighted scans becoming positive as early as 90-120 min post-stroke in rodents 40 and humans. 41 For the sake of completeness, we visually compared post hoc the T2* to the T2 0 maps, which did not reveal more clearly visible lesions (data not shown; see Figure 2 as example). To assess whether our findings are specific to T2 0 , we also generated R2 0 maps (see above), and duplicated the entire visual and ROI analysis, which as expected revealed essentially identical results (data not shown; see Figure 2 as an illustration).
As we used a small sample, our findings need independent replication. However, carrying out both PET and MR after MCAO in the rodent represents a major challenge, and our study is unique. The recent advent of hybrid PET/MR scanners should resolve some of the technical obstacles involved. 42 In conclusion, this study validated T2 0 as a marker of acute brain hypoxia against gold-standard PET, which has important clinical implications. Reproducibility of T2 0 lesion delineation was suboptimal, but further studies should determine if this shortcoming can be overcome by optimizing image acquisition and processing and/or observer experience.
